Growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line

被引:8
|
作者
Li, Hong
Cao, Hou-Fa
Wan, Jun
Li, Yuan
Zhu, Mei-Ling
Zhao, Po [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Nanlou Digest, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Inpatient Dept Med Hlth Ctr, Beijing 100853, Peoples R China
关键词
colonic adenocarcinoma; wild-type Kras2; cell cycle; apoptosis;
D O I
10.3748/wjg.v13.i6.934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To observe the growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line Caco-2. METHODS: Recombinant plasmid pCI-neo-Kras2 with wild type Kras2 open reading frame was constructed. The Caco-2 cells were transfected with either pCI-neo or pCI-neo-Kras2 using Lipofectamine 2000. The expression of wild type Kras2 was examined by Northern blot analysis. And the expression of wild type Kras2 protein was examined by Western blot analysis. The effects of wild-type Kras2 on cell proliferation were analyzed by monotetrazolium (MTT) assay, meanwhile analyses of cell cycle and spontaneous apoptosis rate were carried out by flow cytometry (FCM). RESULTS: The plasmid of pCI-neo-Kras2 was successfully established. The growth rate of cells transfected with pCI-neo-Kras2 was significantly lower than the control cells transfected with the empty pCI-neo vector (P < 0.05). Cell cycle analysis revealed arrest of the pCI-neo-Kras2 transfected cells in G0/G1 phases, decreased DNA synthesis and decreased fractions of cells in S phase. The proliferative index of cells transfected with pCI-neo-Kras2 was decreased compared with the control cells (49.78% vs 64.21%), while the apoptotic rate of Caco-2 cells with stable Kras2 expression increased (0.30% vs 0.02%). CONCLUSION: The wild-type Kra52 gene effectively inhibits the growth of the colonic adenocarcinoma cell line Caco-2. (C) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:934 / 938
页数:5
相关论文
共 50 条
  • [21] Extensive molecular profiling of KRAS wild-type versus KRAS mutant pancreatic ductal adenocarcinoma on 233 patients
    Lena, J.
    Alame, M.
    Italiano, A.
    Soubeyran, I.
    Blouin, L.
    Khalifa, E.
    Cousin, S.
    Pernot, S.
    Palmieri, L-J.
    ANNALS OF ONCOLOGY, 2023, 34 : S904 - S904
  • [22] Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients
    Lena, Jeanne
    Alame, Melissa
    Italiano, Antoine
    Soubeyran, Isabelle
    Blouin, Laura
    Khalifa, Emmanuel
    Cousin, Sophie
    Pernot, Simon
    Palmieri, Lola-Jade
    EUROPEAN JOURNAL OF CANCER, 2025, 216
  • [23] A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
    Mita, Hiroaki
    Toyota, Minoru
    Aoki, Fumio
    Akashi, Hirofumi
    Maruyama, Reo
    Sasaki, Yasushi
    Suzuki, Hiromu
    Idogawa, Masashi
    Kashima, Lisa
    Yanagihara, Kazuyoshi
    Fujita, Masahiro
    Hosokawa, Masao
    Kusano, Masanobu
    Sabau, Sorin Vasile
    Tatsumi, Haruyuki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    Tokino, Takashi
    BMC CANCER, 2009, 9
  • [24] A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
    Hiroaki Mita
    Minoru Toyota
    Fumio Aoki
    Hirofumi Akashi
    Reo Maruyama
    Yasushi Sasaki
    Hiromu Suzuki
    Masashi Idogawa
    Lisa Kashima
    Kazuyoshi Yanagihara
    Masahiro Fujita
    Masao Hosokawa
    Masanobu Kusano
    Sorin Vasile Sabau
    Haruyuki Tatsumi
    Kohzoh Imai
    Yasuhisa Shinomura
    Takashi Tokino
    BMC Cancer, 9
  • [25] Comprehensive genomic profiling (CGP) in KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC).
    George, Ben
    Greenbowe, Joel R.
    Hendifar, Andrew Eugene
    Golan, Talia
    Javle, Milind M.
    Maitra, Anirban
    Bahary, Nathan
    Schrock, Alexa Betzig
    Stephens, Philip J.
    Miller, Vincent A.
    Ross, Jeffrey S.
    Yakirevich, Evgeny
    Ritch, Paul S.
    Thomas, James P.
    Ali, Siraj Mahamed
    Singhi, Aatur D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [26] Comparative analysis of the targetable landscape in KRAS-mutant and wild-type pancreatic adenocarcinoma.
    Knepper, Todd C.
    Kim, Dae Won
    Mauer, Elizabeth
    Ronski, Karyn
    Gulhati, Pat
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma
    Marinovic, Sonja
    Skrtic, Anita
    Catela Ivkovic, Tina
    Poljak, Mirko
    Kapitanovic, Sanja
    HUMAN CELL, 2021, 34 (05) : 1455 - 1465
  • [28] Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma
    Sonja Marinović
    Anita Škrtić
    Tina Catela Ivković
    Mirko Poljak
    Sanja Kapitanović
    Human Cell, 2021, 34 : 1455 - 1465
  • [29] Induction of differentiation by wild-type p53 gene in a human glioma cell line
    Takashi Kokunai
    Atsufumi Kawamura
    Norihiko Tamaki
    Journal of Neuro-Oncology, 1997, 32 : 125 - 133
  • [30] Induction of differentiation by wild-type p53 gene in a human glioma cell line
    Kokunai, T
    Kawamura, A
    Tamaki, N
    JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (02) : 125 - 133